iGMDRD107
Canonical SMILES: CC1=C(C(=NO1)C2=CC=CC=C2)C3=CC=C(C=C3)S(=O)(=O)N
InChI: InChI=1S/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20)
InChI Key: LNPDTQAFDNKSHK-UHFFFAOYSA-N
Drug Class:
AmidesAnalgesicsAnalgesics, Non-NarcoticAnti-Inflammatory AgentsAnti-Inflammatory Agents, Non-SteroidalAntiinflammatory and Antirheumatic ProductsAntiinflammatory and Antirheumatic Products, Non-SteroidsAntirheumatic AgentsAzolesCentral Nervous System AgentsCOX InhibitorsCOX-2 InhibitorsCyclooxygenase InhibitorsCytochrome P-450 Enzyme InhibitorsEnzyme InhibitorsHeterocyclic CompoundsHeterocyclic Compounds, 1-RingMusculo-Skeletal SystemPeripheral Nervous System AgentsSelective Cyclooxygenase 2 Inhibitors (NSAIDs)Sensory System AgentsSulfonesSulfur CompoundsDrug Pathways:
Arachidonic acid metabolismDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in Valdecoxib
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |